Final analysis to be conducted after the earlier of 295 survival events or the FDA-aligned cutoff date; topline results expected by the end of Q2 2024 Prolonged duration of blinded pooled survival in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback